Drugs / PF-0791800 (TTI-621)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02663518 | Jan 2016 → Nov 2022 | cancer, hematopoietic and lymphoid system neoplasm | Pfizer | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-0791800 (TTI-621) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02663518 ↗ |